Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 12, 2024Diagnostic Microbiology and Infectious DiseaseOpen Access

Concordance of targeted and whole genome sequencing for Mycobacterium tuberculosis genotypic drug susceptibility testing

View Full Paper
Ask AI
Bookmark
Share

Authors

WCWilliam Cloutier CharetteUniversité de MontréalMRMarie Sylvianne RabodoariveloUniversidad de ZaragozaFPFloriane PointCentre Hospitalier de l’Université de Montréal

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Charette et al. (2024) studied this question.

synapsesocial.com/papers/68e745afb6db6435876bee27https://doi.org/10.1016/j.diagmicrobio.2024.116249
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeted and whole genome sequencing for drug resistance and genetic relatedness inference of rifampicin resistant <i>Mycobacterium tuberculosis –</i> an in-depth comparison2025 · 3 citations
  2. 2Deep amplicon sequencing for culture-free prediction of susceptibility or resistance to 13 anti-tuberculous drugs2020 · 115 citations
  3. 3Evaluating the Performance of Sputum-Based Targeted Sequencing Against Mycobacterial Whole-Genome Sequencing in Predicting Tuberculosis Drug Resistance2026 · 1 citations
  4. 4Towards culture-free sequencing of Mycobacterium tuberculosis: evaluating new targeted and whole-genome approaches for genotyping and drug resistance profiling2026 · 2 citations
  5. 5Development and Assessment of a Novel Whole-Gene-Based Targeted Next-Generation Sequencing Assay for Detecting the Susceptibility of Mycobacterium tuberculosis to 14 Drugs2022 · 50 citations